QID 378979

Date Published: 2023-10-30

QID 378979: VMware Tools Multiple Security Vulnerability (VMSA-2023-0024)

VMware Tools is a set of services and components that enable several features in various VMware products for better management and seamless user interactions with guest operating systems and improves management of the virtual machine running on VMware.

Affected Versions:
VMware Tools for Windows version 10.3.x
VMware Tools for Windows version 11.x.x.
VMware Tools for Windows version 12.x.x and prior to version 12.3.5

Affected Versions:
VMware Tools for macOS version 10.3.x
VMware Tools for macOS version 11.x.x.
VMware Tools for macOS version 12.x.x and prior to version 12.1.1

QID Detection Logic:(Authenticated)
It checks for vulnerable version of VMware tools.

A malicious actor with local user access to a guest virtual machine may elevate privileges within the virtual machine and A malicious actor that has been granted Guest Operation Privileges in a target virtual machine may be able to elevate their privileges if that target virtual machine has been assigned a more privileged Guest Alias.

CVSS V3 rated as High - 7.8 severity.

CVSS V2 rated as Low - 2.6 severity.

Solution

For more information please visit VMware advisory VMSA-2023-0024

Vendor References

VMSA-2023-0024 - www.vmware.com/security/advisories/VMSA-2023-0024.html

CVEs related to QID 378979

CVE-2023-34057 | CVE-2023-34058 |

Software Advisories

Advisory ID	Software	Component	Link
VMSA-2023-0024			www.vmware.com/security/advisories/VMSA-2023-0024.html

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].